Pan-American Lancehead Pit-Vipers: Coagulotoxic Venom Effects and Antivenom Neutralisation of


Journal

Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 21 12 2020
revised: 10 01 2021
accepted: 17 01 2021
entrez: 27 1 2021
pubmed: 28 1 2021
medline: 2 7 2021
Statut: epublish

Résumé

The toxin composition of snake venoms and, thus, their functional activity, can vary between and within species. Intraspecific venom variation across a species' geographic range is a major concern for antivenom treatment of envenomations, particularly for countries like French Guiana that lack a locally produced antivenom.

Identifiants

pubmed: 33499001
pii: toxins13020078
doi: 10.3390/toxins13020078
pmc: PMC7911261
pii:
doi:

Substances chimiques

Antibodies, Neutralizing 0
Antivenins 0
Crotalid Venoms 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Australian Research Council
ID : DP190100304

Références

Toxicon X. 2020 Apr 23;6:100037
pubmed: 32550592
Toxicon. 1999 Mar;37(3):551-7
pubmed: 10080358
Toxicon. 2016 Nov;122:67-77
pubmed: 27641748
Toxicon. 1984;22(1):115-28
pubmed: 6426093
Toxicon. 1998 Dec;36(12):1749-800
pubmed: 9839663
Toxicol Lett. 2020 Oct 15;333:211-221
pubmed: 32841740
J Proteomics. 2011 Apr 1;74(4):510-27
pubmed: 21278006
Thromb Haemost. 2001 Apr;85(4):710-5
pubmed: 11341509
Toxicon. 2010 Nov;56(6):980-9
pubmed: 20621114
J Proteomics. 2018 Aug 30;186:56-70
pubmed: 30026101
Toxicon. 2020 Jan 15;173:1-4
pubmed: 31726079
Biochemistry. 1979 Aug 7;18(16):3570-7
pubmed: 476069
Toxicon. 2010 Apr 1;55(4):864-73
pubmed: 20026155
Toxins (Basel). 2020 Jul 30;12(8):
pubmed: 32751571
Toxins (Basel). 2016 Oct 26;8(11):
pubmed: 27792190
Anaesth Crit Care Pain Med. 2019 Apr;38(2):193-194
pubmed: 30030082
Toxicon. 2013 Mar 15;64:38-42
pubmed: 23319075
Toxicon. 1999 Feb;37(2):249-52; author reply 253-60
pubmed: 10078860
Toxicol Lett. 2019 Nov;316:35-48
pubmed: 31509773
Trans R Soc Trop Med Hyg. 2009 Sep;103(9):937-42
pubmed: 19144367
PLoS Negl Trop Dis. 2017 Jun 21;11(6):e0005662
pubmed: 28636631
Nature. 1996 Feb 8;379(6565):537-40
pubmed: 8596631
J Venom Anim Toxins Incl Trop Dis. 2014 Mar 06;20(1):7
pubmed: 24602234
Toxicon. 1981;19(6):797-805
pubmed: 7038989
J Proteome Res. 2008 Oct;7(10):4396-408
pubmed: 18785768
Proc Biol Sci. 2009 Jul 7;276(1666):2443-9
pubmed: 19364745
Toxins (Basel). 2020 Oct 19;12(10):
pubmed: 33086750
Haemostasis. 2001 May-Dec;31(3-6):218-24
pubmed: 11910188
Clin Toxicol (Phila). 2020 Apr;58(4):266-274
pubmed: 31264481
Arch Biochem Biophys. 2003 Oct 1;418(1):13-24
pubmed: 13679078
Trop Med Int Health. 2019 Apr;24(4):432-441
pubmed: 30659709
Clin Toxicol (Phila). 2021 Mar;59(3):193-199
pubmed: 32609546
Toxicon. 2009 Dec 1;54(7):998-1011
pubmed: 19591857
Semin Thromb Hemost. 2010 Jun;36(4):444-51
pubmed: 20614396
Toxins (Basel). 2010 Jan;2(1):163-73
pubmed: 22069552
Toxicon. 1995 Nov;33(11):1405-24
pubmed: 8744981
Trans R Soc Trop Med Hyg. 2014 May;108(5):269-76
pubmed: 24619585
Toxicon. 2005 Jun 15;45(8):1133-45
pubmed: 15922779
J Proteomics. 2012 Apr 3;75(7):2181-95
pubmed: 22300577
Toxicol In Vitro. 2019 Aug;58:97-109
pubmed: 30910521
Toxicon. 2006 Jul;48(1):23-8
pubmed: 16750232
Thromb Haemost. 2005 Jul;94(1):123-31
pubmed: 16113795
Toxicol Lett. 2020 Jul 1;327:2-8
pubmed: 32199952
Toxicon. 2004 Mar 15;43(4):417-24
pubmed: 15051405
Biochem J. 2006 Aug 1;397(3):377-87
pubmed: 16831131
PLoS Med. 2008 Nov 4;5(11):e218
pubmed: 18986210
J Med Toxicol. 2017 Dec;13(4):309-320
pubmed: 28975491
Toxicon. 1988;26(11):1067-75
pubmed: 3245051
Toxicon. 2020 Jun;180:39-42
pubmed: 32289355
Comp Biochem Physiol C Toxicol Pharmacol. 2017 Nov;202:39-54
pubmed: 28757215
J Proteomics. 2014 Jun 13;105:340-50
pubmed: 24583507
J Proteomics. 2020 Oct 30;229:103945
pubmed: 32829066
PLoS One. 2017 Nov 27;12(11):e0187969
pubmed: 29176806
Toxins (Basel). 2018 Oct 11;10(10):
pubmed: 30314373
PLoS Negl Trop Dis. 2018 Jul 12;12(7):e0006441
pubmed: 30001319
J Proteomics. 2019 Jan 16;191:153-165
pubmed: 29462664
Toxicon. 2002 Aug;40(8):1107-114
pubmed: 12165312
J Proteome Res. 2008 Aug;7(8):3556-71
pubmed: 18557640
J Venom Anim Toxins Incl Trop Dis. 2015 May 13;21:13
pubmed: 26042152
Toxicon. 1994 Mar;32(3):351-63
pubmed: 8016856

Auteurs

Lachlan A Bourke (LA)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia.

Christina N Zdenek (CN)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia.

Edgar Neri-Castro (E)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

Melisa Bénard-Valle (M)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

Alejandro Alagón (A)

Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnologa, Universidad Nacional Autónoma de México, Av. Universidad 2001, Cuernavaca, Morelos 62210, Mexico.

José María Gutiérrez (JM)

Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José 11501, Costa Rica.

Eladio F Sanchez (EF)

Laboratory of Biochemistry of Proteins from Animal Venoms, Research and Development Center, Ezequiel Dias Foundation, Belo Horizonte, MG 30510-010, Brazil.

Matt Aldridge (M)

MicroPharm Limited, Station Road Ind. Est., Station Road, Newcastle Emlyn, Carmarthenshire SA38 9BY, UK.

Bryan G Fry (BG)

Toxin Evolution Lab, School of Biological Sciences, University of Queensland, St Lucia, QLD 4072, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH